ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC

Clinical trial NCT07012954 · RECRUITING

Trial details

NCT number: NCT07012954
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2025-06-01
Primary completion: 2027-12-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.